Study limitation reported by the research below: “The development cohort (n=145) is small and cognitively impaired (MCI/AD dementia), while the validation cohort (n=1,644) is cognitively unimpaired, making direct performance comparison across cohorts difficult and limiting applicability to populations bridging both groups.”